Log In Sign up
The largest database of trusted experimental protocols
> Chemicals & Drugs > Pharmacologic Substance > Lubricant Eye Drops

Lubricant Eye Drops

Lubricant Eye Drops are specialized ophthalmic solutions used to provide lubrication and relief for dry, irritated eyes.
These drops help maintain the eye's natural tear film, reducing discomfort and promoting ocular health.
Formulated with a variety of lubricating agents, Lubricant Eye Drops can be used to alleviate symptoms associated with dry eye syndrome, computer vision syndrome, and other ocular surface disorders.
When applied as directed, these drops can help soothe, moisturize, and protect the delicate eye tissues, offering a simple and effecitve way to maintain eye comfort and visual clarity. *one typo included*

Most cited protocols related to «Lubricant Eye Drops»

1
Laser-Induced Retinal Lesions in Mice
Cited 16 times
Mice were anesthetized with a mixture of xylazine (6 mg/kg) and ketamine (100 mg/kg), and pupils were dilated with topical drops of Cyclomydril (Alcon Laboratories, Fort Worth, TX). Two minutes after pupil dilation, lubricating eye drops (Alcon Laboratories) were applied to the cornea. The fundus was viewed with an imaging camera, and laser photocoagulation was induced using the image-guided laser system (Micron IV, Phoenix Research Laboratories, Pleasanton, CA). The fundus image as well as the aiming beam can be observed on the monitor screen. Four laser burns at equal distance from the optic nerve were induced one by one in each eye by a green Argon laser pulse with a wavelength of 532 nm, a fixed diameter of 50 μm, duration of 70 ms, and varying power levels from 180 mW to 360 mW. If necessary, an orienting laser shot can also be generated approximately three times of the diameter of the optic nerve to help determine the relative positions of the lesions in an eye. After laser photocoagulation, the eyes were gently rinsed with sterile saline to remove the lubricating eye drops and treated with an antibiotic ointment, erythromycin (Fougera, Melville, NY). Mice were then placed on a pre-warmed warming plate at 35°C after the laser treatment until they awakened.
Gong Y., Li J., Sun Y., Fu Z., Liu C.H., Evans L., Tian K., Saba N., Fredrick T., Morss P., Chen J, & Smith L.E. (2015). Optimization of an Image-Guided Laser-Induced Choroidal Neovascularization Model in Mice. PLoS ONE, 10(7), e0132643.
Full text: Click here
Publication 2015
Antibiotics Argon Ion Lasers Burns Cornea Erythromycin Eye Eye Drops Ketamine Light Coagulation Lubricant Eye Drops Mice, House Mydriasis Ointments Optic Nerve Pulse Rate Pupil Saline Solution Sterility, Reproductive Xylazine
2
Prospective Evaluation of Ocular Neuropathic Pain
Cited 13 times
Patients with normal eyelid and corneal anatomy were prospectively recruited from the Miami Veterans Affairs (VA) Healthcare System eye clinic between October 2013 and October 2017. Patients with scheduled appointments for regular check-ups, for new symptoms related to the eye, or for follow-up appointments, regardless of DE diagnosis, were included as potential participants.
Patients were excluded from participation if they had risk factors accounting for their dry eye symptoms, including: contact lens use, use of ocular medications other than artificial tears, history of refractive surgery, HIV, sarcoidosis, graft-versus host disease or a collagen vascular disease, presence of an active external ocular process, cataract surgery within the last 6 months, history of any glaucoma, or retinal surgery. Participants who did not speak and understand English well were also excluded. Informed consent was obtained from all subjects. Miami VA Institution Review Board approval was obtained to allow the prospective evaluation of subjects. The study was conducted in accordance to the principles of the Declaration of Helsinki and complied with the requirements of the United States Health Insurance Portability and Accountability Act.
In the original NPSI validation paper [8 (link)], the authors included only individuals with at least moderate levels of pain severity (visual analogue scale scores of ≥ 30mm out of 100mm), and for whom pain was due to peripheral or central nervous system injury as indicated by clinical history, laboratory data, and/or imaging. For ocular pain, there is currently no gold standard method to diagnose neuropathic ocular pain nor to verify ocular nervous system lesion. As such, in this paper, we took an inclusive approach, in order to provide a wide range of NPSI scores, and analyzed data from all individuals with reported eye pain, defined as a Numerical Rating Scale (NRS) score of ≥ 1 for average eye pain intensity during the past week.
Farhangi M., Feuer W., Galor A., Bouhassira D., Levitt R.C., Sarantopoulos C.D, & Felix E.R. (2019). Modification of the Neuropathic Pain Symptom Inventory for use in eye pain (NPSI-Eye). Pain, 160(7), 1541-1550.
Publication 2019
Blood Vessel Cataract Extraction Collagen Collagen Diseases Contact Lenses Cornea Diagnosis Dry Eye Ethics Committees, Research Eyelids Glaucoma Gold Graft-vs-Host Disease Inclusion Bodies Lubricant Eye Drops Neuralgia Operative Surgical Procedures Pain Pain, Eye Patient Appointments Patients Pharmaceutical Preparations Retina Sarcoidosis Severity, Pain Surgeries, Refractive Systems, Nervous Trauma, Nervous System Vascular Diseases Veterans Vision Visual Analog Pain Scale
3
Ocular Imaging Procedure for Small Animals
Cited 10 times

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Animals Edema Eyelashes Forehead Gossypium Lens, Crystalline Lubricant Eye Drops Neoplasm Metastasis Nose Saline Solution Tears Viscosity
4
Broad Inclusion for Dry Eye Disease Study
Cited 9 times

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2018
Allergic Conjunctivitis Anesthesia Congenital Abnormality Contact Lenses Cornea Dietary Supplements Dreams Drugs, Non-Prescription Dry Eye Eligibility Determination Eyelids Glaucoma Infection Inflammation Keratomileusis, Laser In Situ Lubricant Eye Drops Operative Surgical Procedures Patients Pharmaceutical Preparations Slit Lamp Examination Vision
5
Peripheral Iridotomies for ICL V4 Implantation
Cited 9 times
Preoperative peripheral iridotomies by neodymium - yttrium - aluminum - garnet (Nd:YAG) laser or intraoperative peripheral iridotomies were performed for ICL V4 implantations and no peripheral iridotomies were performed for ICL V4c implantations. On the day of surgery, all patients were administered with dilating and cycloplegic agents (2.5 % phenylephrine and 1 % tropicamide, Alcon, China). After topical anaesthesia (0.4 % oxybuprocaine hydrochloride, Santen, Japan) and injection of a viscoelastic surgical agent (1.7 % Sodium hyaluronate; Bausch & Lomb, China) into the anterior chamber, an ICL V4 IOL was inserted via a 2.8–3.2 mm temporal clear corneal incision with the use of an injector cartridge (STAAR Surgical). After the ICL was placed in the posterior chamber, the surgeon then completely removed the viscoelastic surgical agent from the eye using a balanced salt solution and instilled a miotic agent (0.005 % carbachol, Bausch & Lomb, China). All surgeries were uneventful and no intraoperative complications were observed. Following surgery, a combination antibacterial and steroidal medication (0.1 % Tobramycin dexamethasone, Alcon, China) was prescribed four times daily for 3 days followed by fluorometholone eyedrops tapered gradually over 2 weeks. Antibiotic eyedrops (0.5 % left Ofloxacin, Santen, Japan) were then prescribed four times daily for 1 week, along with non-steroidal anti-inflammatory eyedrops (NSAID, pranoprofen, Senju, Japan) four times daily for 2 weeks, and artificial tears four times daily for 1 month.
Chen X., Miao H., Naidu R.K., Wang X, & Zhou X. (2016). Comparison of early changes in and factors affecting vault following posterior chamber phakic Implantable Collamer Lens implantation without and with a central hole (ICL V4 and ICL V4c). BMC Ophthalmology, 16(1), 161.
Full text: Click here
Publication 2016
Anti-Bacterial Agents Anti-Inflammatory Agents, Non-Steroidal Antibiotics benoxinate Carbachol Chambers, Anterior Cornea Cycloplegics Eye Drops Fluorometholone Intraoperative Complications Lubricant Eye Drops Miotics Neodymium Neodymium-Doped Yttrium Aluminum Garnet Lasers Ofloxacin Operative Surgical Procedures Ophthalmologic Surgical Procedures Ovum Implantation Patients Pharmaceutical Preparations Phenylephrine pyranoprofen Sodium Chloride Sodium Hyaluronate Steroids Surgeons Surgery, Day Tobramycin, Dexamethasone Drug Combination Topical Anesthetics Tropicamide yttrium-aluminum-garnet

Most recents protocols related to «Lubricant Eye Drops»

1
Bilastine Ophthalmic Solution for Allergic Conjunctivitis
Bilastine 0.6% ophthalmic solution (6 mg/mL) was presented in sterile, preserved solution in ampoules for single use (FAES FARMA S.A., Leioa, Spain). Placebo was the vehicle, with same presentation. Bilastine ophthalmic solution and placebo were identical in color and appearance. The packaging and labelling did not allow for any distinction between test and reference drug. One drop of bilastine or placebo was instilled in each eye once daily in the morning (one ampoule for both eyes). On the days of Visit 2a, Visit 3a and Visit 4a, this was done by a medically qualified person onsite. On the other days, the patient administered one drop in each eye once daily. The duration of treatment for the individual patient was 56 days. The complete study duration (including screening and follow-up) was 70 days. Each patient had to document daily the administration of the ophthalmic solutions in an e-diary.
Prior and concomitant treatment with the following medication and therapies was prohibited: anti-allergy immunotherapy, corticosteroid treatment, depot-corticosteroids, any ophthalmic agents (including artificial tears), systemic or intranasal treatment for allergic rhinitis (ie, antihistamines, mast cell stabilizers, or leukotriene inhibitors).
Kuna P., Jutel M., Pulka G., Tokarski S., Arranz P., Hernández G, & Fernández Hernando N. (2023). Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study. Clinical Ophthalmology (Auckland, N.Z.), 17, 735-746.
Publication 2023
Administration, Intranasal Administration, Ophthalmic Adrenal Cortex Hormones Anti-Allergic Agents bilastine Histamine Antagonists Immunotherapy inhibitors Leukotrienes Lubricant Eye Drops Mast Cell Stabilizer Ophthalmic Solution Patients Pharmaceutical Preparations Pharmacotherapy Placebos Rhinitis, Allergic Sterility, Reproductive
2
Ex Vivo Corneal Permeation of AMP and BLF

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Anesthesia Animal Ethics Committees Animals Bath Cells Cornea Diffusion Drug Overdose Ethanol Eye High-Performance Liquid Chromatographies Ketamine Hydrochloride Lubricant Eye Drops Males New Zealand Rabbits Pentobarbital Sodium Permeability Pharmaceutical Preparations Phosphates Rehabilitation Saline Solution Supervision Tissue Donors Tissues Ultrasonics Veins Veterinarian Xylazine
3
SMILE Lenticule Extraction Protocol
All procedures were performed by the same experienced surgeon (YW). SMILE was performed using the VisuMax femtosecond laser system (Carl Zeiss Meditec AG, Jena, Germany) through a 2-mm tunnel incision at the 12-o’clock position with 130 nJ of energy. The lenticule was created as follows: Posterior surface (from the periphery to the center), border, anterior surface (from the center to the periphery), and side-cut incision. The cap diameter was 7.3–7.6 mm, and the cap thickness was 110–120 µm. The lenticule diameter was 6.3–6.6 mm. A blunt spatula is often used to separate the stromal lenticule before its removal through the tunnel incision. Levofloxacin 0.5% eye drops (Carivid; Santen) were instilled four times a day for 3 days before surgery. Postoperatively, topical levofloxacin 0.5% (Carivid; Santen) was prescribed four times a day for 3 days. Fluoroethylene 0.1% eye drops (Flumetholon; Santen) were prescribed four times daily and tapered off every 2–3 weeks. Artificial tear drops were administered four times a day for 3 months.
Gao W., Zhao X, & Wang Y. (2023). Change in the corneal material mechanical property for small incision lenticule extraction surgery. Frontiers in Bioengineering and Biotechnology, 11, 1034961.
Full text: Click here
Publication 2023
Eye Drops Levofloxacin Lubricant Eye Drops Operative Surgical Procedures Surgeons vinyl fluoride
4
StreamLight PRK Procedure with Mitomycin C
All eyes were treated with the StreamLight® PRK software in WaveLight EX500 Excimer Laser (WaveLight®; Alcon Laboratories, Fort Worth, TX, USA). Postoperative emmetropia was targeted in all eyes and refractive correction was adjusted based on full cycloplegic refraction [13 (link), 14 (link)] with no specific nomograms used. After choosing the StreamLight profile, the epithelial ablation depth was determined based on epithelial mapping in a range between 45 and 65 μm (personal communication with Alcon recommends the use of maximum epithelial thickness) while the epithelial optical zone (OZ) in hyperopic corrections is 8.0 mm as a default setting. The stromal ablation OZ was set to the standard 6.5 mm for all eyes. The total ablation zone (which is a composite ablation zone for both the epithelial and stromal circles) was automatically adjusted to 8.9 mm for both the epithelial and stromal ablations to ensure epithelial-stromal ablation matching. Initially, a drop of a preservative-free local anesthetic was instilled followed by sterilizing the periocular skin and eyelashes with 10% povidone-iodine. An eyelid speculum was inserted and gentle wetting of the cornea with Merocel sponge (Medtronic Inc., Minneapolis, MN, USA) soaked with cold balanced salt solution (BSS, Alcon Lab., Fort Worth, TX, USA) followed by gentle drying was performed. Every patient was instructed to maintain their eye fixation on a green intermittent spotlight. The eye-tracker was activated, and laser ablation was focused and centered on the center of the pupil [15 (link)]. Stream excimer laser firing was started to remove the epithelium followed by stromal ablation in a single step. The manufacturer recommends a momentary stop for 10 s on hearing 3 pop sounds marking the transition between epithelial and stromal ablations to cool down the cornea. Mitomycin C (0.02%) [16 (link), 17 (link)] was applied mid-peripherally for 60 s followed by irrigating the stroma copiously with cold BSS. A soft bandage contact lens was applied until complete epithelial regeneration. An additional movie file shows the surgical steps in more detail (see Additional file 1). Postoperative medications included Moxifloxacin 0.5% eye drops 4 times daily for a week, Fluorometholone 0.1% eye drops twice daily for a month, preservative free artificial tears 5 times daily for 3 months and oral non-steroidal anti-inflammatory pills for post-PRK pain. One surgeon (MA) performed all the TE-PRK surgeries in the study.
Abdel-Radi M., Rateb M., Saleh M.G, & Aly M.O. (2023). Twelve-month outcomes of single-step transepithelial photorefractive keratectomy for moderate hyperopia and hyperopic astigmatism. Eye and Vision, 10, 7.
Full text: Click here
Publication 2023
Anti-Inflammatory Agents, Non-Steroidal Bandage Cold Temperature Contact Lenses, Hydrophilic Contraceptives, Oral Cornea Cycloplegics Epithelium Eye Drops Eyelashes Eyelids Fixation, Ocular Fluorometholone Hallucinations, Auditory Laser Ablation Lasers, Excimer Local Anesthetics Lubricant Eye Drops Merocel Mitomycin Moxifloxacin Ocular Refraction Operative Surgical Procedures Pain Patients Pharmaceutical Preparations Pharmaceutical Preservatives Porifera Povidone Iodine Pupil Regeneration Skin Sodium Chloride Speculum Surgeons
5
Facial Mask Impact on Ocular Health
Healthcare professionals aged between 18 and 40 attending the same workplace environment and wearing surgical facial masks for at least 8 h per day from the beginning of the pandemic (March 2020, since the facial mask use had become mandatory) were included in the study as group 1. Healthy subjects aged between 18 and 40 who had no ocular disease history or ocular complaints and wore facial masks less than 2 h per day or 16 h per week were included in group 2 for comparative analyses. Subjects using glasses or contact lenses, using a different facial mask other than the surgical masks, subjects with active ocular allergy findings (papillary conjunctivitis), corneal vascularization, current or previous history of herpetic keratitis, severe meibomian gland dysfunction, pregnancy, retinal problems or glaucoma, history of ocular surgery, and any systemic or ocular medical treatment, including artificial tear drops, were excluded from the study.
Penbe A., Oklar M., Kanar H.S., Bayrak M.Z., Ersarı B., Talan M., Gün R.D., Orçun A, & Şimşek Ş. (2023). The effects of facial mask use on ocular surface parameters and tear film cytokine profile in prolonged use. International Ophthalmology.
Publication 2023
Administration, Ophthalmic Conjunctivitis Contact Lenses Corneal Neovascularization Eye Eyeglasses Face Glaucoma Health Care Professionals Healthy Volunteers Hypersensitivity Keratitis, Herpetic Lubricant Eye Drops Meibomian Gland Dysfunction Operative Surgical Procedures Pandemics Pregnancy Retina

Top products related to «Lubricant Eye Drops»

1
Vigamox by Alcon
Sourced in United States, Ireland, Germany, Canada
Vigamox is an ophthalmic solution used in the treatment of bacterial conjunctivitis. It contains the active ingredient moxifloxacin hydrochloride, a broad-spectrum fluoroquinolone antibiotic.
2
Cravit by Santen
Sourced in Japan, Ireland, China, United States
Cravit is a laboratory equipment product. It is used for conducting scientific experiments and analyses.
3
Systane ultra by Alcon
Sourced in United States, Switzerland
Systane Ultra is a sterile, preservative-free eye drop solution formulated to provide temporary relief of dry eye symptoms. It contains a unique combination of ingredients designed to help restore the eye's natural tear film.
4
Visumax by Zeiss
Sourced in Germany
The VisuMax is a medical device manufactured by Zeiss. It is a laser system designed for ophthalmological procedures. The VisuMax utilizes a femtosecond laser to perform precise corneal cuts and modifications.
5
Systane ultra lubricant eye drops by Alcon
Sourced in Germany
Systane Ultra Lubricant Eye Drops is a pharmaceutical product designed to provide lubrication and relief for dry eyes. It contains a combination of ingredients, including polyethylene glycol and propylene glycol, which work to replenish the eye's natural tear film and provide long-lasting comfort.
6
Pred forte by Abbvie
Sourced in United States, Ireland
Pred Forte is a prescription eye drop solution that contains the active ingredient prednisolone acetate. It is a corticosteroid medication used to reduce inflammation in the eye.
7
Fluorometholone by Santen
Sourced in Japan
Fluorometholone is a synthetic corticosteroid used in the treatment of various eye conditions. It is a laboratory-produced compound that acts as an anti-inflammatory agent. The core function of Fluorometholone is to reduce inflammation and swelling in the eye.
8
Systane lubricant eye drops by Alcon
Sourced in United States
Systane lubricant eye drops are a sterile, preservative-free formulation designed to provide temporary relief of dry eye symptoms. The main active ingredient is polyethylene glycol, which acts as a lubricant to help retain moisture in the eyes.
9
Tropicamide by Akorn
Sourced in United States, Germany
Tropicamide is a synthetic mydriatic and cycloplegic agent used in ophthalmology. It acts as a competitive antagonist of muscarinic acetylcholine receptors, causing pupil dilation and temporary paralysis of the eye's focusing mechanism.
10
Systane by Alcon
Sourced in United States
Systane is a line of ophthalmic products developed by Alcon, a leading provider of eye care solutions. The core function of Systane is to provide lubrication and hydration for the eyes, helping to alleviate symptoms associated with dry eye disease.

More about "Lubricant Eye Drops"

Lubricant Eye Drops, also known as ophthalmic lubricants or artificial tears, are specialized eye care solutions designed to provide lubrication and relief for dry, irritated eyes.
These drops play a crucial role in maintaining the eye's natural tear film, which is essential for ocular health and comfort.
Formulated with a variety of lubricating agents such as hypromellose, polyethylene glycol, and propylene glycol, Lubricant Eye Drops can effectively alleviate the symptoms associated with dry eye syndrome, computer vision syndrome, and other ocular surface disorders.
When applied as directed, these drops help soothe, moisturize, and protect the delicate eye tissues, offering a simple and effective way to maintain eye comfort and visual clarity.
Related products like Vigamox (moxifloxacin), Cravit (levofloxacin), Systane Ultra, VisuMax (fluorometholone), Pred Forte (prednisolone), and Tropicamide may also be used in conjunction with Lubricant Eye Drops to address specific eye conditions and provide a comprehensive treatment approach.
The combination of Lubricant Eye Drops and these other ophthalmic solutions can help promote overall ocular health and well-being. *one typo included*